Comment on “Prenatal Exposure to Buprenorphine or Methadone and Adverse Neurodevelopmental Outcomes: Population-Based Cohort Study”
Medications for opioid use disorder (MOUD), specifically buprenorphine and methadone, are the recommended treatments during pregnancy because they improve maternal outcomes and reduce adverse neonatal events. Methadone is a full mu-opioid receptor agonist that typically requires daily clinic visits, whereas buprenorphi...